4 completed, 2 withdrawn. 2 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow BMS 747158-02: new trials by email Literature Review of BMS 747158-02 trials Research Report on BMS 747158-02
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD) BMS747158 - Coronary Artery Disease (CAD) | Withdrawn | Lantheus Medical Imaging | 2013-03-01 | 2013-04-04 | ||
| Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI Flurpiridaz F18 - Coronary Artery Disease | Phase 3 | Withdrawn | Lantheus Medical Imaging | 2012-11-01 | 2013-05-30 | |
| A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Flurpiridaz F18, 99mTechnicium (sestamibi or tetrofosmin) - Coronary Artery Disease | Phase 3 | Completed | Lantheus Medical Imaging | 795 | 2011-06-01 | 2020-11-24 |
| Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158 BMS747158 - Ischemia | Phase 2 | Completed | Lantheus Medical Imaging | 176 | 2009-01-01 | 2015-10-14 |
| A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress BMS747158 - Healthy Volunteers | Phase 1 | Completed | Lantheus Medical Imaging | 12 | 2008-06-01 | 2020-11-10 |
| A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158 BMS747158 - Healthy | Phase 1 | Completed | Lantheus Medical Imaging | 13 | 2007-09-01 | 2020-11-10 |
Coronary Artery Disease (4) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Heart Diseases (1) · Ischemia (1) · Vascular Diseases (1)
United States (5) · Canada (1) · Finland (1) · Puerto Rico (1)
Cesare Orlandi, MD (3) · Jamshid Maddahi, MD (2)